{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T13:32:28Z","timestamp":1781530348962,"version":"3.54.1"},"reference-count":140,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["NO.81974182"],"award-info":[{"award-number":["NO.81974182"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171325"],"award-info":[{"award-number":["82171325"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s00415-023-11881-1","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T13:02:19Z","timestamp":1690808539000},"page":"5288-5302","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Movement disorders in autoimmune encephalitis: an update"],"prefix":"10.1007","volume":"270","author":[{"given":"Mengting","family":"Qin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaojiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuying","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"11881_CR1","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1136\/jnnp-2020-325300","volume":"92","author":"H Abboud","year":"2021","unstructured":"Abboud H, Probasco JC, Irani S, Ances B, Benavides DR, Bradshaw M, Christo PP, Dale RC, Fernandez-Fournier M, Flanagan EP, Gadoth A, George P, Grebenciucova E, Jammoul A, Lee ST, Li Y, Matiello M, Morse AM, Rae-Grant A, Rojas G, Rossman I, Schmitt S, Venkatesan A, Vernino S, Pittock SJ, Titulaer MJ (2021) Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. J Neurol Neurosurg Psychiatry 92:757\u2013768","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11881_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/ane.13039","volume":"139","author":"D Dash","year":"2019","unstructured":"Dash D, Pandey S (2019) Movement disorders associated with neuronal antibodies. Acta Neurol Scand 139:106\u2013117","journal-title":"Acta Neurol Scand"},{"key":"11881_CR3","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","volume":"7","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091\u20131098","journal-title":"Lancet Neurol"},{"key":"11881_CR4","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s11910-011-0186-y","volume":"11","author":"SR Irani","year":"2011","unstructured":"Irani SR, Vincent A (2011) NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep 11:298\u2013304","journal-title":"Curr Neurol Neurosci Rep"},{"key":"11881_CR5","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA (2006) Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81:1207\u20131214","journal-title":"Mayo Clin Proc"},{"key":"11881_CR6","first-page":"1169","volume":"31","author":"XQ Xiao","year":"2011","unstructured":"Xiao XQ, Tang N, Liu C, Wang HX, Jiang Q, Deng YJ, Ding YQ (2011) Construction of a PCR chip for detecting genes associated with metastatic colorectal cancer and its preliminary application. Nan Fang Yi Ke Da Xue Xue Bao 31:1169\u20131174","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"11881_CR7","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1001\/jamaneurol.2022.4251","volume":"80","author":"EP Flanagan","year":"2023","unstructured":"Flanagan EP, Geschwind MD, Lopez-Chiriboga AS, Blackburn KM, Turaga S, Binks S, Zitser J, Gelfand JM, Day GS, Dunham SR, Rodenbeck SJ, Clardy SL, Solomon AJ, Pittock SJ, McKeon A, Dubey D, Zekeridou A, Toledano M, Turner LE, Vernino S, Irani SR (2023) Autoimmune encephalitis misdiagnosis in adults. JAMA Neurol 80:30\u201339","journal-title":"JAMA Neurol"},{"key":"11881_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, Cortese I, Dale RC, Gelfand JM, Geschwind M, Glaser CA, Honnorat J, Hoftberger R, Iizuka T, Irani SR, Lancaster E, Leypoldt F, Pruss H, Rae-Grant A, Reindl M, Rosenfeld MR, Rostasy K, Saiz A, Venkatesan A, Vincent A, Wandinger KP, Waters P, Dalmau J (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391\u2013404","journal-title":"Lancet Neurol"},{"key":"11881_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103057","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M (2022) Contemporary advances in anti-NMDAR antibody (Ab)-mediated encephalitis. Autoimmun Rev 21:103057","journal-title":"Autoimmun Rev"},{"key":"11881_CR10","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, Armangue T, Glaser C, Iizuka T, Honig LS, Benseler SM, Kawachi I, Martinez-Hernandez E, Aguilar E, Gresa-Arribas N, Ryan-Florance N, Torrents A, Saiz A, Rosenfeld MR, Balice-Gordon R, Graus F, Dalmau J (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157\u2013165","journal-title":"Lancet Neurol"},{"key":"11881_CR11","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/mds.25999","volume":"29","author":"SS Mohammad","year":"2014","unstructured":"Mohammad SS, Fung VS, Grattan-Smith P, Gill D, Pillai S, Ramanathan S, Brilot F, Dale RC (2014) Movement disorders in children with anti-NMDAR encephalitis and other autoimmune encephalopathies. Mov Disord 29:1539\u20131542","journal-title":"Mov Disord"},{"key":"11881_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/1550059419868919","volume":"51","author":"N Lin","year":"2020","unstructured":"Lin N, Huang Y, Jin L, Lu Q, Liu Q, Zhou X, Guan H (2020) Electroencephalogram and clinical characteristics and correlations in patients with anti-N-methyl-d-aspartate receptor encephalitis. Clin EEG Neurosci 51:51\u201360","journal-title":"Clin EEG Neurosci"},{"key":"11881_CR13","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1093\/brain\/awq113","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655\u20131667","journal-title":"Brain"},{"key":"11881_CR14","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1136\/jnnp-2018-318584","volume":"90","author":"JA Varley","year":"2019","unstructured":"Varley JA, Webb AJS, Balint B, Fung VSC, Sethi KD, Tijssen MAJ, Lynch T, Mohammad SS, Britton F, Evans M, Hacohen Y, Lin JP, Nardocci N, Granata T, Dale RC, Lim MJ, Bhatia KP, Lang AE, Irani SR (2019) The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study. J Neurol Neurosurg Psychiatry 90:724\u2013726","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11881_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/ana.21756","volume":"66","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J (2009) Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66:11\u201318","journal-title":"Ann Neurol"},{"key":"11881_CR16","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1007\/s00415-019-09590-9","volume":"268","author":"S Ramanathan","year":"2021","unstructured":"Ramanathan S, Al-Diwani A, Waters P, Irani SR (2021) The autoantibody-mediated encephalitides: from clinical observations to molecular pathogenesis. J Neurol 268:1689\u20131707","journal-title":"J Neurol"},{"key":"11881_CR17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004365","volume":"95","author":"BC Duan","year":"2016","unstructured":"Duan BC, Weng WC, Lin KL, Wong LC, Li ST, Hsu MH, Lin JJ, Fan PC, Lin MI, Chiu NC, Lin YC, Wang HS, Hung KL, Lee WT (2016) Variations of movement disorders in anti-N-methyl-d-aspartate receptor encephalitis: a nationwide study in Taiwan. Medicine (Baltimore) 95:e4365","journal-title":"Medicine (Baltimore)"},{"key":"11881_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/CCM.0b013e3181cb0968","volume":"38","author":"G Davies","year":"2010","unstructured":"Davies G, Irani SR, Coltart C, Ingle G, Amin Y, Taylor C, Radcliffe J, Hirsch NP, Howard RS, Vincent A, Kullmann DM (2010) Anti-N-methyl-d-aspartate receptor antibodies: a potentially treatable cause of encephalitis in the intensive care unit. Crit Care Med 38:679\u2013682","journal-title":"Crit Care Med"},{"key":"11881_CR19","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1212\/WNL.0000000000002775","volume":"86","author":"N Gresa-Arribas","year":"2016","unstructured":"Gresa-Arribas N, Planaguma J, Petit-Pedrol M, Kawachi I, Katada S, Glaser CA, Simabukuro MM, Armangue T, Martinez-Hernandez E, Graus F, Dalmau J (2016) Human neurexin-3alpha antibodies associate with encephalitis and alter synapse development. Neurology 86:2235\u20132242","journal-title":"Neurology"},{"key":"11881_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/mds.27291","volume":"33","author":"DE Lumsden","year":"2018","unstructured":"Lumsden DE, Allen NM (2018) Rethinking status dystonicus: a welcome start to a challenging problem. Mov Disord 33:344","journal-title":"Mov Disord"},{"key":"11881_CR21","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/dmcn.12108","volume":"55","author":"DE Lumsden","year":"2013","unstructured":"Lumsden DE, Lundy C, Fairhurst C, Lin JP (2013) Dystonia Severity Action Plan: a simple grading system for medical severity of status dystonicus and life-threatening dystonia. Dev Med Child Neurol 55:671\u2013672","journal-title":"Dev Med Child Neurol"},{"key":"11881_CR22","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00415-023-11599-0","volume":"270","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Cui L, Chen W, Huang H, Liu G, Su Y, Boltze J (2023) Status dystonicus in adult patients with anti-N-methyl-d-aspartate-acid receptor encephalitis. J Neurol 270:2693\u20132701","journal-title":"J Neurol"},{"key":"11881_CR23","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.3389\/fneur.2019.01330","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Zhang L, Chi XS, He L, Zhou D, Li JM (2019) Psychiatric symptoms of patients with anti-NMDA receptor encephalitis. Front Neurol 10:1330","journal-title":"Front Neurol"},{"key":"11881_CR24","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1017\/S0033291719003283","volume":"51","author":"N Warren","year":"2021","unstructured":"Warren N, O\u2019Gorman C, McKeon G, Swayne A, Blum S, Siskind D (2021) Psychiatric management of anti-NMDAR encephalitis: a cohort analysis. Psychol Med 51:435\u2013440","journal-title":"Psychol Med"},{"key":"11881_CR25","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12888-022-04505-x","volume":"23","author":"H Wu","year":"2023","unstructured":"Wu H, Wu C, Zhou Y, Huang S, Zhu S (2023) Catatonia in adult anti-NMDAR encephalitis: an observational cohort study. BMC Psychiatry 23:94","journal-title":"BMC Psychiatry"},{"key":"11881_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/02698811231158232","volume":"37","author":"JP Rogers","year":"2023","unstructured":"Rogers JP, Oldham MA, Fricchione G, Northoff G, Ellen WJ, Mann SC, Francis A, Wieck A, Elizabeth WL, Lewis G, Grover S, Hirjak D, Ahuja N, Zandi MS, Young AH, Fone K, Andrews S, Kessler D, Saifee T, Gee S, Baldwin DS, David AS (2023) Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 37:327\u2013369","journal-title":"J Psychopharmacol"},{"key":"11881_CR27","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1007\/s00415-016-8282-1","volume":"263","author":"Q Huang","year":"2016","unstructured":"Huang Q, Wu Y, Qin R, Wei X, Ma M (2016) Clinical characteristics and outcomes between children and adults with anti-N-Methyl-d-Aspartate receptor encephalitis. J Neurol 263:2446\u20132455","journal-title":"J Neurol"},{"key":"11881_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.seizure.2021.02.023","volume":"90","author":"A Lizcano-Meneses","year":"2021","unstructured":"Lizcano-Meneses A, Watanabe N, von Glehn F, Barbosa R, de Albuquerque M, Yassuda C, Moraes AS, Martinez JW, Santos LMB, Cendes F (2021) Clinical variables that help in predicting the presence of autoantibodies in patients with acute encephalitis. Seizure 90:117\u2013122","journal-title":"Seizure"},{"key":"11881_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103074","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M (2022) Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides. Autoimmun Rev 21:103074","journal-title":"Autoimmun Rev"},{"key":"11881_CR30","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/ana.22307","volume":"69","author":"SR Irani","year":"2011","unstructured":"Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJ, Alessandro SZ, Bleasel A, Somerville ER, Smith SM, Vincent A (2011) Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69:892\u2013900","journal-title":"Ann Neurol"},{"key":"11881_CR31","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S1474-4422(10)70137-X","volume":"9","author":"M Lai","year":"2010","unstructured":"Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9:776\u2013785","journal-title":"Lancet Neurol"},{"key":"11881_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1212\/WNL.0b013e31825f0522","volume":"79","author":"GK Tofaris","year":"2012","unstructured":"Tofaris GK, Irani SR, Cheeran BJ, Baker IW, Cader ZM, Vincent A (2012) Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis. Neurology 79:195\u2013196","journal-title":"Neurology"},{"key":"11881_CR33","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82:79\u201392","journal-title":"Ann Neurol"},{"key":"11881_CR34","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.parkreldis.2015.08.014","volume":"21","author":"MM Kurtis","year":"2015","unstructured":"Kurtis MM, Toledano R, Garcia-Morales I, Gil-Nagel A (2015) Immunomodulated parkinsonism as a presenting symptom of LGI1 antibody encephalitis. Parkinsonism Relat Disord 21:1286\u20131287","journal-title":"Parkinsonism Relat Disord"},{"key":"11881_CR35","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1212\/WNL.0b013e3182152808","volume":"76","author":"DM Andrade","year":"2011","unstructured":"Andrade DM, Tai P, Dalmau J, Wennberg R (2011) Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis? Neurology 76:1355\u20131357","journal-title":"Neurology"},{"key":"11881_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1684\/epd.2018.1010","volume":"20","author":"G D\u2019Orsi","year":"2018","unstructured":"D\u2019Orsi G, Martino T, Lalla A, Claudio MTD, Carapelle E, Avolio C (2018) Faciobrachial dystonic seizures expressed as epileptic spasms, followed by focal seizures in anti-LGI1 encephalitis: a video-polygraphic study. Epileptic Disord 20:525\u2013529","journal-title":"Epileptic Disord"},{"key":"11881_CR37","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1684\/epd.2017.0936","volume":"19","author":"NJ Beimer","year":"2017","unstructured":"Beimer NJ, Selwa LM (2017) Seizure semiology of anti-LGI1 antibody encephalitis. Epileptic Disord 19:461\u2013464","journal-title":"Epileptic Disord"},{"key":"11881_CR38","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1001\/jamaneurol.2016.1085","volume":"73","author":"TA Fantaneanu","year":"2016","unstructured":"Fantaneanu TA, Bhattacharyya S, Milligan TA, Pennell PB (2016) Rapidly cycling auras and episodic focal dystonia in anti-LGI1 autoimmune encephalitis. JAMA Neurol 73:1150","journal-title":"JAMA Neurol"},{"key":"11881_CR39","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1093\/brain\/aww012","volume":"139","author":"V Navarro","year":"2016","unstructured":"Navarro V, Kas A, Apartis E, Chami L, Rogemond V, Levy P, Psimaras D, Habert MO, Baulac M, Delattre JY, Honnorat J (2016) Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis. Brain 139:1079\u20131093","journal-title":"Brain"},{"key":"11881_CR40","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1093\/brain\/awt212","volume":"136","author":"SR Irani","year":"2013","unstructured":"Irani SR, Stagg CJ, Schott JM, Rosenthal CR, Schneider SA, Pettingill P, Pettingill R, Waters P, Thomas A, Voets NL, Cardoso MJ, Cash DM, Manning EN, Lang B, Smith SJ, Vincent A, Johnson MR (2013) Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 136:3151\u20133162","journal-title":"Brain"},{"key":"11881_CR41","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/jnnp-2017-315720","volume":"89","author":"SNM Binks","year":"2018","unstructured":"Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR (2018) LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes. J Neurol Neurosurg Psychiatry 89:526\u2013534","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11881_CR42","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1093\/brain\/awx323","volume":"141","author":"J Thompson","year":"2018","unstructured":"Thompson J, Bi M, Murchison AG, Makuch M, Bien CG, Chu K, Farooque P, Gelfand JM, Geschwind MD, Hirsch LJ, Somerville E, Lang B, Vincent A, Leite MI, Waters P, Irani SR (2018) The importance of early immunotherapy in patients with faciobrachial dystonic seizures. Brain 141:348\u2013356","journal-title":"Brain"},{"key":"11881_CR43","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000161","volume":"2","author":"EP Flanagan","year":"2015","unstructured":"Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ (2015) Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurol Neuroimmunol Neuroinflamm 2:e161","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11881_CR44","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1111\/ene.15384","volume":"29","author":"J Mo","year":"2022","unstructured":"Mo J, Dong W, Cui T, Chen C, Shi W, Hu W, Zhang C, Wang X, Zhang K, Shao X (2022) Whole-brain metabolic pattern analysis in patients with anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis. Eur J Neurol 29:2376\u20132385","journal-title":"Eur J Neurol"},{"key":"11881_CR45","doi-asserted-by":"publisher","first-page":"2734","DOI":"10.1093\/brain\/awq213","volume":"133","author":"SR Irani","year":"2010","unstructured":"Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A (2010) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan\u2019s syndrome and acquired neuromyotonia. Brain 133:2734\u20132748","journal-title":"Brain"},{"key":"11881_CR46","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000371","volume":"4","author":"B Joubert","year":"2017","unstructured":"Joubert B, Gobert F, Thomas L, Saint-Martin M, Desestret V, Convers P, Rogemond V, Picard G, Ducray F, Psimaras D, Antoine JC, Delattre JY, Honnorat J (2017) Autoimmune episodic ataxia in patients with anti-CASPR2 antibody-associated encephalitis. Neurol Neuroimmunol Neuroinflamm 4:e371","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11881_CR47","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1001\/jamaneurol.2016.1585","volume":"73","author":"B Joubert","year":"2016","unstructured":"Joubert B, Saint-Martin M, Noraz N, Picard G, Rogemond V, Ducray F, Desestret V, Psimaras D, Delattre JY, Antoine JC, Honnorat J (2016) Characterization of a subtype of autoimmune encephalitis with anti-contactin-associated protein-like 2 antibodies in the cerebrospinal fluid, prominent limbic symptoms, and seizures. JAMA Neurol 73:1115\u20131124","journal-title":"JAMA Neurol"},{"key":"11881_CR48","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/brain\/awac276","volume":"146","author":"F Govert","year":"2023","unstructured":"Govert F, Abrante L, Becktepe J, Balint B, Ganos C, Hofstadt-van OU, Krogias C, Varley J, Irani SR, Paneva S, Titulaer MJ, de Vries JM, Boon AJW, Schreurs MWJ, Joubert B, Honnorat J, Vogrig A, Arino H, Sabater L, Dalmau J, Scotton S, Jacob S, Melzer N, Bien CG, Geis C, Lewerenz J, Pruss H, Wandinger KP, Deuschl G, Leypoldt F (2023) Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis. Brain 146:657\u2013667","journal-title":"Brain"},{"key":"11881_CR49","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jns.2013.01.040","volume":"327","author":"B Balint","year":"2013","unstructured":"Balint B, Regula JU, Jarius S, Wildemann B (2013) Caspr2 antibodies in limbic encephalitis with cerebellar ataxia, dyskinesias and myoclonus. J Neurol Sci 327:73\u201374","journal-title":"J Neurol Sci"},{"key":"11881_CR50","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1212\/WNL.0000000000002917","volume":"87","author":"A van Sonderen","year":"2016","unstructured":"van Sonderen A, Arino H, Petit-Pedrol M, Leypoldt F, Kortvelyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MW, Sillevis SPA, Graus F, Dalmau J, Titulaer MJ (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87:521\u2013528","journal-title":"Neurology"},{"key":"11881_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9:67\u201376","journal-title":"Lancet Neurol"},{"key":"11881_CR52","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/brain\/awz094","volume":"142","author":"MH van Coevorden-Hameete","year":"2019","unstructured":"van Coevorden-Hameete MH, de Bruijn M, de Graaff E, Bastiaansen D, Schreurs MWJ, Demmers JAA, Ramberger M, Hulsenboom ESP, Nagtzaam MMP, Boukhrissi S, Veldink JH, Verschuuren J, Hoogenraad CC, Sillevis SPAE, Titulaer MJ (2019) The expanded clinical spectrum of anti-GABABR encephalitis and added value of KCTD16 autoantibodies. Brain 142:1631\u20131643","journal-title":"Brain"},{"key":"11881_CR53","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001158","volume":"9","author":"B Deng","year":"2022","unstructured":"Deng B, Cai M, Qiu Y, Liu X, Yu H, Zhang X, Huang H, Zhao X, Yang W, Dong S, Jin L, Chu S, Chen X (2022) MRI characteristics of autoimmune encephalitis with autoantibodies to GABAA receptor: a case series. Neurol Neuroimmunol Neuroinflamm 9:e1158","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11881_CR54","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","volume":"81","author":"R Hoftberger","year":"2013","unstructured":"Hoftberger R, Titulaer MJ, Sabater L, Dome B, Rozsas A, Hegedus B, Hoda MA, Laszlo V, Ankersmit HJ, Harms L, Boyero S, de Felipe A, Saiz A, Dalmau J, Graus F (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81:1500\u20131506","journal-title":"Neurology"},{"key":"11881_CR55","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","volume":"88","author":"M Spatola","year":"2017","unstructured":"Spatola M, Petit-Pedrol M, Simabukuro MM, Armangue T, Castro FJ, Barcelo AMI, Julia BMR, Benson L, Gorman M, Felipe A, Caparo ORL, Rosenfeld MR, Graus F, Dalmau J (2017) Investigations in GABA(A) receptor antibody-associated encephalitis. Neurology 88:1012\u20131020","journal-title":"Neurology"},{"key":"11881_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1002\/ana.21917","volume":"67","author":"MP Malter","year":"2010","unstructured":"Malter MP, Helmstaedter C, Urbach H, Vincent A, Bien CG (2010) Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 67:470\u2013478","journal-title":"Ann Neurol"},{"key":"11881_CR57","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ane.13281","volume":"142","author":"F Zhu","year":"2020","unstructured":"Zhu F, Shan W, Lv R, Li Z, Wang Q (2020) Clinical characteristics of GAD 65-associated autoimmune encephalitis. Acta Neurol Scand 142:281\u2013293","journal-title":"Acta Neurol Scand"},{"key":"11881_CR58","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/jnnp-2020-325275","volume":"92","author":"A Budhram","year":"2021","unstructured":"Budhram A, Sechi E, Flanagan EP, Dubey D, Zekeridou A, Shah SS, Gadoth A, Naddaf E, McKeon A, Pittock SJ, Zalewski NL (2021) Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry 92:645\u2013654","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11881_CR59","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1007\/s13311-022-01188-w","volume":"19","author":"MC Dalakas","year":"2022","unstructured":"Dalakas MC (2022) Stiff-person syndrome and GAD antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies. Neurotherapeutics 19:832\u2013847","journal-title":"Neurotherapeutics"},{"key":"11881_CR60","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/brain\/awh532","volume":"128","author":"C Pierrot-Deseilligny","year":"2005","unstructured":"Pierrot-Deseilligny C, Milea D (2005) Vertical nystagmus: clinical facts and hypotheses. Brain 128:1237\u20131246","journal-title":"Brain"},{"key":"11881_CR61","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nrneurol.2012.99","volume":"8","author":"E Lancaster","year":"2012","unstructured":"Lancaster E, Dalmau J (2012) Neuronal autoantigens\u2013pathogenesis, associated disorders and antibody testing. Nat Rev Neurol 8:380\u2013390","journal-title":"Nat Rev Neurol"},{"key":"11881_CR62","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1212\/WNL.0000000000001682","volume":"84","author":"R Hoftberger","year":"2015","unstructured":"Hoftberger R, van Sonderen A, Leypoldt F, Houghton D, Geschwind M, Gelfand J, Paredes M, Sabater L, Saiz A, Titulaer MJ, Graus F, Dalmau J (2015) Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients. Neurology 84:2403\u20132412","journal-title":"Neurology"},{"key":"11881_CR63","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1002\/ana.23756","volume":"73","author":"A Boronat","year":"2013","unstructured":"Boronat A, Gelfand JM, Gresa-Arribas N, Jeong HY, Walsh M, Roberts K, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R, Graus F, Rudy B, Dalmau J (2013) Encephalitis and antibodies to dipeptidyl-peptidase-like protein-6, a subunit of Kv4.2 potassium channels. Ann Neurol 73:120\u2013128","journal-title":"Ann Neurol"},{"key":"11881_CR64","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1212\/WNL.0000000000000991","volume":"83","author":"WO Tobin","year":"2014","unstructured":"Tobin WO, Lennon VA, Komorowski L, Probst C, Clardy SL, Aksamit AJ, Appendino JP, Lucchinetti CF, Matsumoto JY, Pittock SJ, Sandroni P, Tippmann-Peikert M, Wirrell EC, McKeon A (2014) DPPX potassium channel antibody: frequency, clinical accompaniments, and outcomes in 20 patients. Neurology 83:1797\u20131803","journal-title":"Neurology"},{"key":"11881_CR65","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1212\/WNL.0000000000003796","volume":"88","author":"M Hara","year":"2017","unstructured":"Hara M, Arino H, Petit-Pedrol M, Sabater L, Titulaer MJ, Martinez-Hernandez E, Schreurs MW, Rosenfeld MR, Graus F, Dalmau J (2017) DPPX antibody-associated encephalitis: main syndrome and antibody effects. Neurology 88:1340\u20131348","journal-title":"Neurology"},{"key":"11881_CR66","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C, Graus F, Compta Y, Hogl B, Bataller L, Bruggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Marti MJ, Montojo T, Perez-Perez J, Puertas I, Seitz C, Simabukuro M, Tellez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaria J, Dalmau J (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88:1736\u20131743","journal-title":"Neurology"},{"key":"11881_CR67","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12974-016-0689-1","volume":"13","author":"L Sabater","year":"2016","unstructured":"Sabater L, Planaguma J, Dalmau J, Graus F (2016) Cellular investigations with human antibodies associated with the anti-IgLON5 syndrome. J Neuroinflamm 13:226","journal-title":"J Neuroinflamm"},{"key":"11881_CR68","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1002\/mdc3.13061","volume":"7","author":"S Aslam","year":"2020","unstructured":"Aslam S, Shill H (2020) Chorea in IgLON5-mediated autoimmune encephalitis. Mov Disord Clin Pract 7:S83\u2013S84","journal-title":"Mov Disord Clin Pract"},{"key":"11881_CR69","doi-asserted-by":"publisher","first-page":"3453","DOI":"10.1093\/brain\/aws256","volume":"135","author":"RC Dale","year":"2012","unstructured":"Dale RC, Merheb V, Pillai S, Wang D, Cantrill L, Murphy TK, Ben-Pazi H, Varadkar S, Aumann TD, Horne MK, Church AJ, Fath T, Brilot F (2012) Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders. Brain 135:3453\u20133468","journal-title":"Brain"},{"key":"11881_CR70","volume":"8","author":"S Kalampokini","year":"2023","unstructured":"Kalampokini S, Motkova I, Bargiotas P, Artemiadis A, Zis P, Hadjigeorgiou GM (2023) A case of unusual presentation with anti-glycine receptor (GlyR) and myelin oligodentrocyte glycoprotein (MOG) antibody. Clin Park Relat Disord 8:100195","journal-title":"Clin Park Relat Disord"},{"key":"11881_CR71","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s10072-022-06458-1","volume":"44","author":"M Ren","year":"2023","unstructured":"Ren M, Zhou Q (2023) Stroke-like presentation of autoimmune chorea with positive anti-Yo and anti-MOG antibodies: a case report. Neurol Sci 44:347\u2013349","journal-title":"Neurol Sci"},{"key":"11881_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102018","volume":"42","author":"C Hou","year":"2020","unstructured":"Hou C, Wu W, Tian Y, Zhang Y, Zhu H, Zeng Y, Peng B, Zheng K, Li X, Chen W (2020) Clinical analysis of anti-NMDAR encephalitis combined with MOG antibody in children. Mult Scler Relat Disord 42:102018","journal-title":"Mult Scler Relat Disord"},{"key":"11881_CR73","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1007\/s00415-021-10934-7","volume":"269","author":"A Sturchio","year":"2022","unstructured":"Sturchio A, Dwivedi AK, Gastaldi M, Grimberg MB, Businaro P, Duque KR, Vizcarra JA, Abdelghany E, Balint B, Marsili L, Espay AJ (2022) Movement disorders associated with neuronal antibodies: a data-driven approach. J Neurol 269:3511\u20133521","journal-title":"J Neurol"},{"key":"11881_CR74","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3389\/fneur.2019.01394","volume":"10","author":"MP Giannoccaro","year":"2019","unstructured":"Giannoccaro MP, Wright SK, Vincent A (2019) In vivo mechanisms of antibody-mediated neurological disorders: animal models and potential implications. Front Neurol 10:1394","journal-title":"Front Neurol"},{"key":"11881_CR75","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/s41380-017-0011-3","volume":"24","author":"H Pan","year":"2019","unstructured":"Pan H, Oliveira B, Saher G, Dere E, Tapken D, Mitjans M, Seidel J, Wesolowski J, Wakhloo D, Klein-Schmidt C, Ronnenberg A, Schwabe K, Trippe R, Matz-Rensing K, Berghoff S, Al-Krinawe Y, Martens H, Begemann M, Stocker W, Kaup FJ, Mischke R, Boretius S, Nave KA, Krauss JK, Hollmann M, Luhder F, Ehrenreich H (2019) Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model. Mol Psychiatry 24:1489\u20131501","journal-title":"Mol Psychiatry"},{"key":"11881_CR76","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw0044","author":"BE Jones","year":"2019","unstructured":"Jones BE, Tovar KR, Goehring A, Jalali-Yazdi F, Okada NJ, Gouaux E, Westbrook GL (2019) Autoimmune receptor encephalitis in mice induced by active immunization with conformationally stabilized holoreceptors. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaw0044","journal-title":"Sci Transl Med"},{"key":"11881_CR77","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12974-021-02107-0","volume":"18","author":"Y Ding","year":"2021","unstructured":"Ding Y, Zhou Z, Chen J, Peng Y, Wang H, Qiu W, Xie W, Zhang J, Wang H (2021) Anti-NMDAR encephalitis induced in mice by active immunization with a peptide from the amino-terminal domain of the GluN1 subunit. J Neuroinflamm 18:53","journal-title":"J Neuroinflamm"},{"key":"11881_CR78","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000529","volume":"6","author":"J Linnoila","year":"2019","unstructured":"Linnoila J, Pulli B, Armangue T, Planaguma J, Narsimhan R, Schob S, Zeller MWG, Dalmau J, Chen J (2019) Mouse model of anti-NMDA receptor post-herpes simplex encephalitis. Neurol Neuroimmunol Neuroinflamm 6:e529","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11881_CR79","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1002\/mds.25072","volume":"27","author":"M Stamelou","year":"2012","unstructured":"Stamelou M, Plazzi G, Lugaresi E, Edwards MJ, Bhatia KP (2012) The distinct movement disorder in anti-NMDA receptor encephalitis may be related to status dissociatus: a hypothesis. Mov Disord 27:1360\u20131363","journal-title":"Mov Disord"},{"key":"11881_CR80","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1093\/sleep\/14.1.69","volume":"14","author":"MW Mahowald","year":"1991","unstructured":"Mahowald MW, Schenck CH (1991) Status dissociates\u2014a perspective on states of being. Sleep 14:69\u201379","journal-title":"Sleep"},{"key":"11881_CR81","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1002\/mds.22073","volume":"23","author":"TJ Kleinig","year":"2008","unstructured":"Kleinig TJ, Thompson PD, Matar W, Duggins A, Kimber TE, Morris JG, Kneebone CS, Blumbergs PC (2008) The distinctive movement disorder of ovarian teratoma-associated encephalitis. Mov Disord 23:1256\u20131261","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"11881_CR82","doi-asserted-by":"publisher","first-page":"s225","DOI":"10.1007\/s10072-005-0492-8","volume":"26","author":"CA Tassinari","year":"2005","unstructured":"Tassinari CA, Rubboli G, Gardella E, Cantalupo G, Calandra-Buonaura G, Vedovello M, Alessandria M, Gandini G, Cinotti S, Zamponi N, Meletti S (2005) Central pattern generators for a common semiology in fronto-limbic seizures and in parasomnias. A neuroethologic approach. Neurol Sci 26(Suppl 3):s225\u2013s232","journal-title":"Neurol Sci"},{"key":"11881_CR83","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/j.1528-1167.2010.02756.x","volume":"52","author":"T Lalic","year":"2011","unstructured":"Lalic T, Pettingill P, Vincent A, Capogna M (2011) Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia 52:121\u2013131","journal-title":"Epilepsia"},{"key":"11881_CR84","first-page":"3144","volume":"141","author":"M Petit-Pedrol","year":"2018","unstructured":"Petit-Pedrol M, Sell J, Planaguma J, Mannara F, Radosevic M, Haselmann H, Ceanga M, Sabater L, Spatola M, Soto D, Gasull X, Dalmau J, Geis C (2018) LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory. Brain 141:3144\u20133159","journal-title":"Brain"},{"key":"11881_CR85","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1002\/ana.25666","volume":"87","author":"HC Kornau","year":"2020","unstructured":"Kornau HC, Kreye J, Stumpf A, Fukata Y, Parthier D, Sammons RP, Imbrosci B, Kurpjuweit S, Kowski AB, Fukata M, Pruss H, Schmitz D (2020) Human cerebrospinal fluid monoclonal lgi1 autoantibodies increase neuronal excitability. Ann Neurol 87:405\u2013418","journal-title":"Ann Neurol"},{"key":"11881_CR86","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0272277","volume":"17","author":"E Fels","year":"2022","unstructured":"Fels E, Mayeur ME, Wayere E, Vincent C, Malleval C, Honnorat J, Pascual O (2022) Dysregulation of the hippocampal neuronal network by LGI1 auto-antibodies. PLoS ONE 17:e0272277","journal-title":"PLoS ONE"},{"key":"11881_CR87","doi-asserted-by":"publisher","unstructured":"Baudin P, Roussel D, Mahon S, Charpier S, Navarro V (2023) In vivo injection of anti-LGI1 antibodies into the rodent M1 cortex and hippocampus is ineffective in inducing seizures. eNeuro. https:\/\/doi.org\/10.1523\/ENEURO.0267-22.2023","DOI":"10.1523\/ENEURO.0267-22.2023"},{"key":"11881_CR88","doi-asserted-by":"publisher","first-page":"7719","DOI":"10.1073\/pnas.1618656114","volume":"114","author":"M Seagar","year":"2017","unstructured":"Seagar M, Russier M, Caillard O, Maulet Y, Fronzaroli-Molinieres L, De San FM, Boumedine-Guignon N, Rodriguez L, Zbili M, Usseglio F, Formisano-Treziny C, Youssouf F, Sangiardi M, Boillot M, Baulac S, Benitez MJ, Garrido JJ, Debanne D, El FO (2017) LGI1 tunes intrinsic excitability by regulating the density of axonal Kv1 channels. Proc Natl Acad Sci USA 114:7719\u20137724","journal-title":"Proc Natl Acad Sci USA"},{"key":"11881_CR89","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1212\/01.wnl.0000326572.93762.51","volume":"71","author":"SR Irani","year":"2008","unstructured":"Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, Smith S (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71:1647\u20131648","journal-title":"Neurology"},{"key":"11881_CR90","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3389\/fneur.2020.00280","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Yu Y, Hu Y, Li Y, Song F, Wang Y (2020) Clinical and electroencephalographic features of the seizures in neuronal surface antibody-associated autoimmune encephalitis. Front Neurol 11:280","journal-title":"Front Neurol"},{"key":"11881_CR91","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/ana.22470","volume":"70","author":"P Striano","year":"2011","unstructured":"Striano P (2011) Faciobrachial dystonic attacks: seizures or movement disorder? Ann Neurol 70:179\u2013180 (author reply 180)","journal-title":"Ann Neurol"},{"key":"11881_CR92","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s00415-013-6946-7","volume":"260","author":"F Boesebeck","year":"2013","unstructured":"Boesebeck F, Schwarz O, Dohmen B, Graef U, Vestring T, Kramme C, Bien CG (2013) Faciobrachial dystonic seizures arise from cortico-subcortical abnormal brain areas. J Neurol 260:1684\u20131686","journal-title":"J Neurol"},{"key":"11881_CR93","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200034","volume":"9","author":"T Kaaden","year":"2022","unstructured":"Kaaden T, Madlener M, Angstwurm K, Bien CG, Bogarin Y, Doppler K, Finke A, Gerner ST, Reimann G, Hausler M, Handreka R, Hellwig K, Kaufmann M, Kellinghaus C, Koertvelyessy P, Kraft A, Lewerenz J, Menge T, Paliantonis A, von Podewils F, Pruss H, Rauer S, Ringelstein M, Rostasy K, Schirotzek I, Schwabe J, Sokolowski P, Suesse M, Suhs KW, Surges R, Tauber SC, Thaler F, Bergh FT, Urbanek C, Wandinger KP, Wildemann B, Mues S, Zettl U, Leypoldt F, Melzer N, Geis C, Malter M, Kunze A (2022) Seizure semiology in antibody-associated autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm 9:e200034","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"11881_CR94","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ebcr.2017.06.001","volume":"8","author":"RS Iyer","year":"2017","unstructured":"Iyer RS, Ramakrishnan TCR, Karunakaran SA, Kamaleshwaran KK (2017) Faciobrachial dystonic seizures result from fronto-temporo-basalganglial network involvement. Epilepsy Behav Case Rep 8:47\u201350","journal-title":"Epilepsy Behav Case Rep"},{"key":"11881_CR95","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1111\/cns.13707","volume":"27","author":"TR Li","year":"2021","unstructured":"Li TR, Zhang YD, Wang Q, Shao XQ, Lv RJ (2021) Recognition of seizure semiology and semiquantitative FDG-PET analysis of anti-LGI1 encephalitis. CNS Neurosci Ther 27:1173\u20131181","journal-title":"CNS Neurosci Ther"},{"key":"11881_CR96","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.0013-9580.2004.45403.x","volume":"45","author":"M Mizobuchi","year":"2004","unstructured":"Mizobuchi M, Matsuda K, Inoue Y, Sako K, Sumi Y, Chitoku S, Tsumaki K, Takahashi M (2004) Dystonic posturing associated with putaminal hyperperfusion depicted on subtraction SPECT. Epilepsia 45:948\u2013953","journal-title":"Epilepsia"},{"key":"11881_CR97","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/ana.25120","volume":"83","author":"KR Patterson","year":"2018","unstructured":"Patterson KR, Dalmau J, Lancaster E (2018) Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia. Ann Neurol 83:40\u201351","journal-title":"Ann Neurol"},{"key":"11881_CR98","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/acn3.50919","volume":"6","author":"M Romoli","year":"2019","unstructured":"Romoli M, Krashia P, Sen A, Franciotta D, Gastaldi M, Nobili A, Mancini A, Nardi CE, Nigro P, Tambasco N, Mercuri NB, Parnetti L, Di Filippo M, D\u2019Amelio M, Irani SR, Costa C, Calabresi P (2019) Hippocampal epileptogenesis in autoimmune encephalitis. Ann Clin Transl Neurol 6:2261\u20132269","journal-title":"Ann Clin Transl Neurol"},{"key":"11881_CR99","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.26345","volume":"91","author":"B Joubert","year":"2022","unstructured":"Joubert B, Petit-Pedrol M, Planaguma J, Mannara F, Radosevic M, Marsal M, Maudes E, Garcia-Serra A, Aguilar E, Andres-Bilbe A, Gasull X, Loza-Alvarez P, Sabater L, Rosenfeld MR, Dalmau J (2022) Human CASPR2 antibodies reversibly alter memory and the CASPR2 protein complex. Ann Neurol 91:801\u2013813","journal-title":"Ann Neurol"},{"key":"11881_CR100","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1212\/WNL.0b013e318247cd03","volume":"78","author":"EE Benarroch","year":"2012","unstructured":"Benarroch EE (2012) GABAB receptors: structure, functions, and clinical implications. Neurology 78:578\u2013584","journal-title":"Neurology"},{"key":"11881_CR101","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.neuron.2010.03.012","volume":"66","author":"JR Chalifoux","year":"2010","unstructured":"Chalifoux JR, Carter AG (2010) GABAB receptors modulate NMDA receptor calcium signals in dendritic spines. Neuron 66:101\u2013113","journal-title":"Neuron"},{"key":"11881_CR102","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/epi4.12067","volume":"2","author":"A Nibber","year":"2017","unstructured":"Nibber A, Mann EO, Pettingill P, Waters P, Irani SR, Kullmann DM, Vincent A, Lang B (2017) Pathogenic potential of antibodies to the GABA(B) receptor. Epilepsia Open 2:355\u2013359","journal-title":"Epilepsia Open"},{"key":"11881_CR103","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1002\/ana.24498","volume":"78","author":"Ankit Jain","year":"2015","unstructured":"Jain Ankit, Lancaster Eric, Dalmau Josep, Balice-Gordon Rita J, Philadelphia PA, Cambridge MA, Barcelona, (2015) Autoantibodies in the CSF of anti-GABABReceptor encephalitis patients block activation of GABAB receptors in vitro. Ann Neurol 78:S77\u2013S77. https:\/\/doi.org\/10.1002\/ana.24498","journal-title":"Ann Neurol"},{"key":"11881_CR104","volume":"218","author":"J Kreye","year":"2021","unstructured":"Kreye J, Wright SK, van Casteren A, Stoffler L, Machule ML, Reincke SM, Nikolaus M, van Hoof S, Sanchez-Sendin E, Homeyer MA, Cordero GC, Kornau HC, Schmitz D, Kaindl AM, Boehm-Sturm P, Mueller S, Wilson MA, Upadhya MA, Dhangar DR, Greenhill S, Woodhall G, Turko P, Vida I, Garner CC, Wickel J, Geis C, Fukata Y, Fukata M, Pruss H (2021) Encephalitis patient-derived monoclonal GABAA receptor antibodies cause epileptic seizures. J Exp Med 218:e20210012","journal-title":"J Exp Med"},{"key":"11881_CR105","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1916337118","volume":"118","author":"SM Brandle","year":"2021","unstructured":"Brandle SM, Cerina M, Weber S, Held K, Menke AF, Alcala C, Gebert D, Herrmann AM, Pellkofer H, Gerdes LA, Bittner S, Leypoldt F, Teegen B, Komorowski L, Kumpfel T, Hohlfeld R, Meuth SG, Casanova B, Melzer N, Beltran E, Dornmair K (2021) Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA(A) receptor encephalitis. Proc Natl Acad Sci USA 118:e1916337118","journal-title":"Proc Natl Acad Sci USA"},{"key":"11881_CR106","doi-asserted-by":"publisher","first-page":"3707","DOI":"10.3390\/ijms23073707","volume":"23","author":"AF Menke","year":"2022","unstructured":"Menke AF, Ismail FS, Dornmair K, Cerina M, Meuth SG, Melzer N (2022) GABA(A) receptor autoantibodies decrease GABAergic synaptic transmission in the hippocampal CA3 network. Int J Mol Sci 23:3707","journal-title":"Int J Mol Sci"},{"key":"11881_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103118","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N, Butzkueven H, O\u2019Brien TJ, Monif M (2022) Rare antibody-mediated and seronegative autoimmune encephalitis: an update. Autoimmun Rev 21:103118","journal-title":"Autoimmun Rev"},{"key":"11881_CR108","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s12028-019-00875-5","volume":"32","author":"F Ali","year":"2020","unstructured":"Ali F, Wijdicks EF (2020) Treatment of movement disorder emergencies in autoimmune encephalitis in the neurosciences ICU. Neurocrit Care 32:286\u2013294","journal-title":"Neurocrit Care"},{"key":"11881_CR109","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/jnnp-2021-327302","volume":"93","author":"A Rodriguez","year":"2022","unstructured":"Rodriguez A, Klein CJ, Sechi E, Alden E, Basso MR, Pudumjee S, Pittock SJ, McKeon A, Britton JW, Lopez-Chiriboga AS, Zekeridou A, Zalewski NL, Boeve BF, Day GS, Gadoth A, Burkholder D, Toledano M, Dubey D, Flanagan EP (2022) LGI1 antibody encephalitis: acute treatment comparisons and outcome. J Neurol Neurosurg Psychiatry 93:309\u2013315","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11881_CR110","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/00000542-200604000-00021","volume":"104","author":"S Kingston","year":"2006","unstructured":"Kingston S, Mao L, Yang L, Arora A, Fibuch EE, Wang JQ (2006) Propofol inhibits phosphorylation of N-methyl-d-aspartate receptor NR1 subunits in neurons. Anesthesiology 104:763\u2013769","journal-title":"Anesthesiology"},{"key":"11881_CR111","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1007\/s12630-020-01753-x","volume":"67","author":"F Coluzzi","year":"2020","unstructured":"Coluzzi F, Angelini A, Simmaco M, Alampi D, Alessandri E, Grassi E, Monina MG, Rocco M (2020) The effect of dexmedetomidine on status epilepticus in a patient with anti-NMDA receptor encephalitis. Can J Anaesth 67:1677\u20131679","journal-title":"Can J Anaesth"},{"key":"11881_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2021.110509","volume":"75","author":"MS Yeh","year":"2021","unstructured":"Yeh MS, Chen GY, Lin CH, Lin CY (2021) A combination of midazolam and dexmedetomidine for anesthesia management in a patient with anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis: a case report. J Clin Anesth 75:110509","journal-title":"J Clin Anesth"},{"key":"11881_CR113","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1213\/ANE.0b013e31822b8a7d","volume":"113","author":"PG Pryzbylkowski","year":"2011","unstructured":"Pryzbylkowski PG, Dunkman WJ, Liu R, Chen L (2011) Case report: anti-N-methyl-d-aspartate receptor encephalitis and its anesthetic implications. Anesth Analg 113:1188\u20131191","journal-title":"Anesth Analg"},{"key":"11881_CR114","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12871-017-0379-2","volume":"17","author":"L Ding","year":"2017","unstructured":"Ding L, Tan H, Li Z, Ji J, Song X (2017) Case report: anaesthetic management of radical gastrectomy for gastric cancer associated with anti-N-methyl-d-aspartate receptor encephalitis. BMC Anesthesiol 17:90","journal-title":"BMC Anesthesiol"},{"key":"11881_CR115","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1471-2253-14-5","volume":"14","author":"FX Lapebie","year":"2014","unstructured":"Lapebie FX, Kennel C, Magy L, Projetti F, Honnorat J, Pichon N, Vignon P, Francois B (2014) Potential side effect of propofol and sevoflurane for anesthesia of anti-NMDA-R encephalitis. BMC Anesthesiol 14:5","journal-title":"BMC Anesthesiol"},{"key":"11881_CR116","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/sja.SJA_720_19","volume":"14","author":"GF Al","year":"2020","unstructured":"Al GF, Uffman JC, Kim SS, Nafiu OO, Tobias JD (2020) Anesthetic care for patients with anti-NMDA receptor encephalitis. Saudi J Anaesth 14:164\u2013168","journal-title":"Saudi J Anaesth"},{"key":"11881_CR117","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1186\/s40064-016-3079-3","volume":"5","author":"D Yamanaka","year":"2016","unstructured":"Yamanaka D, Kawano T, Tateiwa H, Iwata H, Locatelli FM, Yokoyama M (2016) Successful management of dexmedetomidine for postoperative intensive care sedation in a patient with anti-NMDA receptor encephalitis: a case report and animal experiment. Springerplus 5:1380","journal-title":"Springerplus"},{"key":"11881_CR118","first-page":"530","volume":"75","author":"YH Hwang","year":"2022","unstructured":"Hwang YH, Shon Y, Yoon YJ, Yeom JH (2022) Anesthesia for ovarian teratoma resection using remimazolam and remifentanil in a patient with anti-N-methyl-d-aspartate receptor encephalitis\u2014two case reports. Korean J Anesthesiol 75:530\u2013535","journal-title":"Korean J Anesthesiol"},{"key":"11881_CR119","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1007\/s13311-020-00944-0","volume":"17","author":"IO Bledsoe","year":"2020","unstructured":"Bledsoe IO, Viser AC, San LM (2020) Treatment of dystonia: medications, neurotoxins, neuromodulation, and rehabilitation. Neurotherapeutics 17:1622\u20131644","journal-title":"Neurotherapeutics"},{"key":"11881_CR120","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mds.26300","volume":"30","author":"M Deffains","year":"2015","unstructured":"Deffains M, Bergman H (2015) Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease. Mov Disord 30:1014\u20131025","journal-title":"Mov Disord"},{"key":"11881_CR121","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/archneur.1995.00540280095022","volume":"52","author":"DD Truong","year":"1995","unstructured":"Truong DD, Sandroni P, van den Noort S, Matsumoto RR (1995) Diphenhydramine is effective in the treatment of idiopathic dystonia. Arch Neurol 52:405\u2013407","journal-title":"Arch Neurol"},{"key":"11881_CR122","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/mds.870030107","volume":"3","author":"P Greene","year":"1988","unstructured":"Greene P, Shale H, Fahn S (1988) Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 3:46\u201360","journal-title":"Mov Disord"},{"key":"11881_CR123","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/1531-8257(200011)15:6<1242::AID-MDS1028>3.0.CO;2-Z","volume":"15","author":"RH Walker","year":"2000","unstructured":"Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF (2000) Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 15:1242\u20131247","journal-title":"Mov Disord"},{"key":"11881_CR124","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3171\/jns.2006.105.1.71","volume":"105","author":"AL Albright","year":"2006","unstructured":"Albright AL (2006) Intraventricular baclofen infusion for dystonia. Report of two cases. J Neurosurg 105:71\u201374","journal-title":"J Neurosurg"},{"key":"11881_CR125","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fneur.2018.00081","volume":"9","author":"F Zheng","year":"2018","unstructured":"Zheng F, Ye X, Shi X, Poonit ND, Lin Z (2018) Management of refractory orofacial dyskinesia caused by anti-N-methyl-d-aspartate receptor encephalitis using botulinum toxin. Front Neurol 9:81","journal-title":"Front Neurol"},{"key":"11881_CR126","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s11940-018-0529-y","volume":"20","author":"E Feinstein","year":"2018","unstructured":"Feinstein E, Walker R (2018) An update on the treatment of chorea. Curr Treat Options Neurol 20:44","journal-title":"Curr Treat Options Neurol"},{"key":"11881_CR127","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/mds.25354","volume":"28","author":"JF Baizabal-Carvallo","year":"2013","unstructured":"Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J (2013) The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 28:543\u2013547","journal-title":"Mov Disord"},{"key":"11881_CR128","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.pediatrneurol.2014.10.011","volume":"52","author":"Y Yushvayev-Cavalier","year":"2015","unstructured":"Yushvayev-Cavalier Y, Nichter C, Ramirez-Zamora A (2015) Possible autoimmune association between herpes simplex virus infection and subsequent anti-N-methyl-d-aspartate receptor encephalitis: a pediatric patient with abnormal movements. Pediatr Neurol 52:454\u2013456","journal-title":"Pediatr Neurol"},{"key":"11881_CR129","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.pediatrneurol.2012.12.032","volume":"48","author":"V Cantarin-Extremera","year":"2013","unstructured":"Cantarin-Extremera V, Duat-Rodriguez A, Gonzalez-Gutierrez-Solana L, Lopez-Marin L, Armangue T (2013) Clinical case of anti-N-methyl-d-aspartate receptor encephalitis in an 8-month-old patient with hyperkinetic movement disorder. Pediatr Neurol 48:400\u2013402","journal-title":"Pediatr Neurol"},{"key":"11881_CR130","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1212\/WNL.44.5.821","volume":"44","author":"U Bonuccelli","year":"1994","unstructured":"Bonuccelli U, Ceravolo R, Maremmani C, Nuti A, Rossi G, Muratorio A (1994) Clozapine in Huntington\u2019s chorea. Neurology 44:821\u2013823","journal-title":"Neurology"},{"key":"11881_CR131","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4485","volume":"366","author":"V Shanker","year":"2019","unstructured":"Shanker V (2019) Essential tremor: diagnosis and management. BMJ 366:l4485","journal-title":"BMJ"},{"key":"11881_CR132","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1007\/s13311-020-00922-6","volume":"17","author":"AB Pena","year":"2020","unstructured":"Pena AB, Caviness JN (2020) Physiology-based treatment of myoclonus. Neurotherapeutics 17:1665\u20131680","journal-title":"Neurotherapeutics"},{"key":"11881_CR133","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1111\/dmcn.12882","volume":"58","author":"SS Mohammad","year":"2016","unstructured":"Mohammad SS, Jones H, Hong M, Nosadini M, Sharpe C, Pillai SC, Brilot F, Dale RC (2016) Symptomatic treatment of children with anti-NMDAR encephalitis. Dev Med Child Neurol 58:376\u2013384","journal-title":"Dev Med Child Neurol"},{"key":"11881_CR134","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/jnnp-2017-316583","volume":"89","author":"R Iorio","year":"2018","unstructured":"Iorio R, Damato V, Evoli A, Gessi M, Gaudino S, Di Lazzaro V, Spagni G, Sluijs JA, Hol EM (2018) Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients. J Neurol Neurosurg Psychiatry 89:138\u2013146","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"11881_CR135","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1001\/jamaneurol.2016.2549","volume":"73","author":"B Fang","year":"2016","unstructured":"Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA (2016) Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis. JAMA Neurol 73:1297\u20131307","journal-title":"JAMA Neurol"},{"key":"11881_CR136","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/mds.25354","volume":"28","author":"JF Baizabal-Carvallo","year":"2013","unstructured":"Baizabal-Carvallo JF, Stocco A, Muscal E, Jankovic J (2013) The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord 28:543\u2013547","journal-title":"Mov Disord"},{"key":"11881_CR137","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA (2006) Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81:1207\u20131214","journal-title":"Mayo Clin Proc"},{"key":"11881_CR138","doi-asserted-by":"publisher","first-page":"e1964","DOI":"10.1212\/WNL.0000000000005614","volume":"90","author":"M Spatola","year":"2018","unstructured":"Spatola M, Sabater L, Planaguma J, Martinez-Hernandez E, Armangue T, Pruss H, Iizuka T, Caparo Oblitas RL, Antoine JC, Li R, Heaney N, Tubridy N, Munteis Olivas E, Rosenfeld MR, Graus F, Dalmau J (2018) Encephalitis with mGluR5 antibodies: symptoms and antibody effects. Neurology 90:e1964\u2013e1972","journal-title":"Neurology"},{"key":"11881_CR139","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/02698811231158232","volume":"37","author":"JP Rogers","year":"2023","unstructured":"Rogers JP, Oldham MA, Fricchione G, Northoff G, Ellen WJ, Mann SC, Francis A, Wieck A, Elizabeth WL, Lewis G, Grover S, Hirjak D, Ahuja N, Zandi MS, Young AH, Fone K, Andrews S, Kessler D, Saifee T, Gee S, Baldwin DS, David AS (2023) Evidence-based consensus guidelines for the management of catatonia: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 37:327\u2013369","journal-title":"J Psychopharmacol"},{"key":"11881_CR140","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/mds.27446","volume":"33","author":"V Damato","year":"2018","unstructured":"Damato V, Balint B, Kienzler AK, Irani SR (2018) The clinical features, underlying immunology, and treatment of autoantibody-mediated movement disorders. Mov Disord 33:1376\u20131389","journal-title":"Mov Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11881-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-023-11881-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-023-11881-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T09:06:11Z","timestamp":1697274371000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-023-11881-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":140,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["11881"],"URL":"https:\/\/doi.org\/10.1007\/s00415-023-11881-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no declarations of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}